SME Times is powered by   
Search News
Just in:   • India's wholesale inflation stands at 12.29 pc in October: Govt  • India, Egypt target $12 billion in bilateral trade  • India, Egypt have exciting opportunities in transforming transport, supply chain infra  • India targets 6 cr Lakhpati Didis by 2029 as beneficiary count reaches 3.76 crore  • India's solar module capacity jumps 15-fold to 116 GW on PLI push 
Last updated: 20 Jun, 2017  

cadila.thumb.jpg Zydus Cadila gets USFDA nod for migraine drug

cadila.jpg
   Top Stories
» India, Egypt target $12 billion in bilateral trade
» Indian markets trade higher in early deals; IT, banking shares rally
» RBI issues consolidated domestic money transfer rules; retains Rs 50,000 cash NEFT cap
» Indian stock markets closed on account of Diwali-Balipratipada
» Govt launches 20 critical mineral blocks, unveils ANVESH and EKAM portals
SME Times News Bureau | 20 Jun, 2017
Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

According to the company, the drug with strengths 20mg and 40mg will be produced at the group's formulations manufacturing facility at the Pharma SEZ (special economic zone) in Ahmedabad.

"The group now has more than 120 approvals and has so far filed over 300 ANDAs (abbreviated new drug applications ) since the commencement of the filing process in FY 2003-04," the firm said in a regulatory filing with the BSE. 
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter